Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Piper Sandler Downgrades NGM Biopharmaceuticals to Neutral

Piper Sandler analyst Swapnil Malekar downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Overweight to Neutral.

October 17, 2022

1 minute read

Piper Sandler analyst Swapnil Malekar downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Overweight to Neutral.

Caesars, NYRA Bets Plan To Launch New Horse Racing Wagering App

Today, 9:19 AM

Caesars Entertainment Inc (NASDAQ:CZR) Caesars Sportsbook division, in partnership with NYRABets LLC (NYRA Bets), plans to launch a new…

Today, 9:19 AM

Morgan Stanley analyst Simon Flannery maintains Anterix (NASDAQ:ATEX) with a Equal-Weight and raises the price target from $51 to $65.

Today, 9:19 AM

https://variety.com/2022/digital/news/dolphin-entertainment-female-led-nft-collection-the-flower-girls-1235195210/

Today, 9:19 AM

- Reuters